194 related articles for article (PubMed ID: 26895379)
21. Selective inhibition of IDO1, D-1-methyl-tryptophan (D-1MT), effectively increased EpCAM/CD3-bispecific BiTE antibody MT110 efficacy against IDO1
Hong R; Zhou Y; Tian X; Wang L; Wu X
Int Immunopharmacol; 2018 Jan; 54():118-124. PubMed ID: 29128855
[TBL] [Abstract][Full Text] [Related]
22. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
[TBL] [Abstract][Full Text] [Related]
23. Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
Folgiero V; Goffredo BM; Filippini P; Masetti R; Bonanno G; Caruso R; Bertaina V; Mastronuzzi A; Gaspari S; Zecca M; Torelli GF; Testi AM; Pession A; Locatelli F; Rutella S
Oncotarget; 2014 Apr; 5(8):2052-64. PubMed ID: 24903009
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory investigation of niacin derivatives on metalloenzyme indoleamine 2,3-dioxygenase 1 for its immunomodulatory function.
Yan D; Xu J; Tan X
Metallomics; 2021 Feb; 13(3):. PubMed ID: 33638642
[TBL] [Abstract][Full Text] [Related]
25. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8
Dey S; Sutanto-Ward E; Kopp KL; DuHadaway J; Mondal A; Ghaban D; Lecoq I; Zocca MB; Merlo LMF; Mandik-Nayak L; Andersen MH; Pedersen AW; Muller AJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690770
[TBL] [Abstract][Full Text] [Related]
26. Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma.
Ishio T; Goto S; Tahara K; Tone S; Kawano K; Kitano S
J Gastroenterol Hepatol; 2004 Mar; 19(3):319-26. PubMed ID: 14748880
[TBL] [Abstract][Full Text] [Related]
27. High expression of IDO1 and TGF-β1 during recurrence and post infection clearance with Chlamydia trachomatis, are independent of host IFN-γ response.
Ziklo N; Huston WM; Taing K; Timms P
BMC Infect Dis; 2019 Mar; 19(1):218. PubMed ID: 30832593
[TBL] [Abstract][Full Text] [Related]
28. Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival.
Zhai L; Ladomersky E; Lauing KL; Wu M; Genet M; Gritsina G; Győrffy B; Brastianos PK; Binder DC; Sosman JA; Giles FJ; James CD; Horbinski C; Stupp R; Wainwright DA
Clin Cancer Res; 2017 Nov; 23(21):6650-6660. PubMed ID: 28751450
[No Abstract] [Full Text] [Related]
29. Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy.
Gomes B; Driessens G; Bartlett D; Cai D; Cauwenberghs S; Crosignani S; Dalvie D; Denies S; Dillon CP; Fantin VR; Guo J; Letellier MC; Li W; Maegley K; Marillier R; Miller N; Pirson R; Rabolli V; Ray C; Streiner N; Torti VR; Tsaparikos K; Van den Eynde BJ; Wythes M; Yao LC; Zheng X; Tumang J; Kraus M
Mol Cancer Ther; 2018 Dec; 17(12):2530-2542. PubMed ID: 30232146
[TBL] [Abstract][Full Text] [Related]
30. Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1.
Moretti S; Menicali E; Nucci N; Voce P; Colella R; Melillo RM; Liotti F; Morelli S; Fallarino F; Macchiarulo A; Santoro M; Avenia N; Puxeddu E
J Biol Chem; 2017 Feb; 292(5):1785-1797. PubMed ID: 27994058
[TBL] [Abstract][Full Text] [Related]
31. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
[TBL] [Abstract][Full Text] [Related]
32. Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells.
Que Z; Zou F; Zhang A; Zheng Y; Bi L; Zhong J; Tian J; Liu J
Int Immunopharmacol; 2014 Nov; 23(1):192-204. PubMed ID: 25138378
[TBL] [Abstract][Full Text] [Related]
33. Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma.
Meireson A; Ferdinande L; Haspeslagh M; Hennart B; Allorge D; Ost P; Sundahl N; Spaas M; Demeyer A; Brochez L
Front Immunol; 2021; 12():736498. PubMed ID: 34557196
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
Orabona C; Mondanelli G; Pallotta MT; Carvalho A; Albini E; Fallarino F; Vacca C; Volpi C; Belladonna ML; Berioli MG; Ceccarini G; Esposito SM; Scattoni R; Verrotti A; Ferretti A; De Giorgi G; Toni S; Cappa M; Matteoli MC; Bianchi R; Matino D; Iacono A; Puccetti M; Cunha C; Bicciato S; Antognelli C; Talesa VN; Chatenoud L; Fuchs D; Pilotte L; Van den Eynde B; Lemos MC; Romani L; Puccetti P; Grohmann U
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563329
[TBL] [Abstract][Full Text] [Related]
35. Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.
Romani R; Pirisinu I; Calvitti M; Pallotta MT; Gargaro M; Bistoni G; Vacca C; Di Michele A; Orabona C; Rosati J; Pirro M; Giovagnoli S; Matino D; Prontera P; Rosi G; Grohmann U; Talesa VN; Donti E; Puccetti P; Fallarino F
J Cell Mol Med; 2015 Jul; 19(7):1593-605. PubMed ID: 25783564
[TBL] [Abstract][Full Text] [Related]
36. Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway.
Mei J; Li MQ; Ding D; Li DJ; Jin LP; Hu WG; Zhu XY
Int J Clin Exp Pathol; 2013; 6(3):431-44. PubMed ID: 23411497
[TBL] [Abstract][Full Text] [Related]
37. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
Bonanno G; Mariotti A; Procoli A; Folgiero V; Natale D; De Rosa L; Majolino I; Novarese L; Rocci A; Gambella M; Ciciarello M; Scambia G; Palumbo A; Locatelli F; De Cristofaro R; Rutella S
J Transl Med; 2012 Dec; 10():247. PubMed ID: 23232072
[TBL] [Abstract][Full Text] [Related]
38. Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers.
Noonepalle SK; Gu F; Lee EJ; Choi JH; Han Q; Kim J; Ouzounova M; Shull AY; Pei L; Hsu PY; Kolhe R; Shi F; Choi J; Chiou K; Huang TH; Korkaya H; Deng L; Xin HB; Huang S; Thangaraju M; Sreekumar A; Ambs S; Tang SC; Munn DH; Shi H
Cancer Immunol Res; 2017 Apr; 5(4):330-344. PubMed ID: 28264810
[TBL] [Abstract][Full Text] [Related]
39.
Bando H; Lee Y; Sakaguchi N; Pradipta A; Sakamoto R; Tanaka S; Ma JS; Sasai M; Yamamoto M
Front Cell Infect Microbiol; 2019; 9():140. PubMed ID: 31119110
[No Abstract] [Full Text] [Related]
40. Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s).
Guo F; Hu M; Huang D; Zhao Y; Heng B; Guillemin G; Lim CK; Hawthorne WJ; Yi S
Xenotransplantation; 2017 Sep; 24(5):. PubMed ID: 28771838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]